Vanguard Group’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.8M | Buy |
7,651,157
+244,813
| +3% | +$2.33M | ﹤0.01% | 1962 |
|
|
2025
Q1 | $77.5M | Buy |
7,406,344
+702,418
| +10% | +$7.35M | ﹤0.01% | 1901 |
|
|
2024
Q4 | $158M | Sell |
6,703,926
-160,211
| -2% | -$3.77M | ﹤0.01% | 1646 |
|
|
2024
Q3 | $247M | Buy |
6,864,137
+2,146,083
| +45% | +$77.1M | ﹤0.01% | 1433 |
|
|
2024
Q2 | $167M | Buy |
4,718,054
+1,277,784
| +37% | +$45.1M | ﹤0.01% | 1591 |
|
|
2024
Q1 | $97.7M | Buy |
3,440,270
+1,110,629
| +48% | +$31.5M | ﹤0.01% | 1885 |
|
|
2023
Q4 | $31M | Sell |
2,329,641
-34,673
| -1% | -$461K | ﹤0.01% | 2395 |
|
|
2023
Q3 | $21.2M | Sell |
2,364,314
-24,427
| -1% | -$219K | ﹤0.01% | 2527 |
|
|
2023
Q2 | $26.9M | Buy |
2,388,741
+941,984
| +65% | +$10.6M | ﹤0.01% | 2465 |
|
|
2023
Q1 | $16.7M | Sell |
1,446,757
-197,653
| -12% | -$2.28M | ﹤0.01% | 2670 |
|
|
2022
Q4 | $19.1M | Buy |
1,644,410
+306,045
| +23% | +$3.55M | ﹤0.01% | 2651 |
|
|
2022
Q3 | $17M | Buy |
1,338,365
+17,140
| +1% | +$218K | ﹤0.01% | 2704 |
|
|
2022
Q2 | $9.08M | Sell |
1,321,225
-72,716
| -5% | -$500K | ﹤0.01% | 3049 |
|
|
2022
Q1 | $13.4M | Buy |
1,393,941
+1,219
| +0.1% | +$11.8K | ﹤0.01% | 2993 |
|
|
2021
Q4 | $16.6M | Buy |
1,392,722
+99,380
| +8% | +$1.18M | ﹤0.01% | 2940 |
|
|
2021
Q3 | $21M | Buy |
1,293,342
+78,459
| +6% | +$1.27M | ﹤0.01% | 2839 |
|
|
2021
Q2 | $25.6M | Buy |
1,214,883
+340,910
| +39% | +$7.17M | ﹤0.01% | 2722 |
|
|
2021
Q1 | $13.6M | Buy |
873,973
+183,391
| +27% | +$2.85M | ﹤0.01% | 2994 |
|
|
2020
Q4 | $14.5M | Buy |
690,582
+645,582
| +1,435% | +$13.6M | ﹤0.01% | 2799 |
|
|
2020
Q3 | $908K | Buy |
+45,000
| New | +$908K | ﹤0.01% | 3679 |
|